tiprankstipranks
Advertisement
Advertisement

HK:2487 Stock Latest News

Cutia Therapeutics Changes Cayman Share Registrar Name Without Moving Registered Office
Company AnnouncementsCutia Therapeutics Changes Cayman Share Registrar Name Without Moving Registered Office
1d ago
2487
Cutia Therapeutics Sets 2026 AGM to Vote on Board, Auditor and Share Mandates
PremiumCompany Announcements
Cutia Therapeutics Sets 2026 AGM to Vote on Board, Auditor and Share Mandates
5d ago
2487
Cutia Therapeutics’ Botox Rival Meets Phase III Goals in China
PremiumCompany Announcements
Cutia Therapeutics’ Botox Rival Meets Phase III Goals in China
16d ago
2487
Cutia Therapeutics Boosts Revenue and Margins as Key Dermatology Products Launch in 2025
PremiumCompany Announcements
Cutia Therapeutics Boosts Revenue and Margins as Key Dermatology Products Launch in 2025
1M ago
2487
Cutia Therapeutics Wins China Trial Nod for New Topical Hair-Loss Drug
PremiumCompany Announcements
Cutia Therapeutics Wins China Trial Nod for New Topical Hair-Loss Drug
1M ago
2487
Cutia Therapeutics Sets March 2026 Board Meeting to Approve 2025 Annual Results
PremiumCompany AnnouncementsCutia Therapeutics Sets March 2026 Board Meeting to Approve 2025 Annual Results
2M ago
2487
Cutia Therapeutics’ Botulinum Toxin CU-20101 Meets Phase III Goals in China
Premium
Company Announcements
Cutia Therapeutics’ Botulinum Toxin CU-20101 Meets Phase III Goals in China
3M ago
2487
Cutia Therapeutics Reshapes Board with Resignation of Dr. Huang and Appointment of Veteran Executive Lu Minfang
Premium
Company Announcements
Cutia Therapeutics Reshapes Board with Resignation of Dr. Huang and Appointment of Veteran Executive Lu Minfang
4M ago
2487
Cutia Therapeutics Updates Board and Committee Structure
PremiumCompany Announcements
Cutia Therapeutics Updates Board and Committee Structure
4M ago
2487
Cutia Therapeutics’ Topical Finasteride Spray Gains Regulatory Acceptance
PremiumCompany Announcements
Cutia Therapeutics’ Topical Finasteride Spray Gains Regulatory Acceptance
5M ago
2487
Cutia Therapeutics’ Acne Treatment Shows Promising Early Results
PremiumCompany Announcements
Cutia Therapeutics’ Acne Treatment Shows Promising Early Results
6M ago
2487
Cutia Therapeutics Completes HK$240 Million Share Placement
PremiumCompany Announcements
Cutia Therapeutics Completes HK$240 Million Share Placement
8M ago
2487
Cutia Therapeutics to Raise HK$240 Million Through Share Placement
PremiumCompany AnnouncementsCutia Therapeutics to Raise HK$240 Million Through Share Placement
8M ago
2487
Cutia Therapeutics Announces Board Changes
Premium
Company Announcements
Cutia Therapeutics Announces Board Changes
8M ago
2487
Cutia Therapeutics Announces Board Composition and Committee Roles
Premium
Company Announcements
Cutia Therapeutics Announces Board Composition and Committee Roles
8M ago
2487
Cutia Therapeutics Forms Nomination Committee to Enhance Governance
PremiumCompany Announcements
Cutia Therapeutics Forms Nomination Committee to Enhance Governance
8M ago
2487
Cutia Therapeutics Announces Key Administrative Changes and Office Relocation
PremiumCompany Announcements
Cutia Therapeutics Announces Key Administrative Changes and Office Relocation
8M ago
2487
Cutia Therapeutics Advances in Dermatology with New Product Approvals
PremiumCompany Announcements
Cutia Therapeutics Advances in Dermatology with New Product Approvals
8M ago
2487
Cutia Therapeutics Schedules Board Meeting for Interim Results Review
PremiumCompany Announcements
Cutia Therapeutics Schedules Board Meeting for Interim Results Review
8M ago
2487
Cutia Therapeutics Gains Hong Kong Approval for Topical Finasteride Spray
PremiumCompany AnnouncementsCutia Therapeutics Gains Hong Kong Approval for Topical Finasteride Spray
9M ago
2487
Cutia Therapeutics Gains Approval for Innovative Hair Loss Treatment in China
Premium
Company Announcements
Cutia Therapeutics Gains Approval for Innovative Hair Loss Treatment in China
10M ago
2487
Cutia Therapeutics’ Phase III Trial Results for CU-30101 Accepted for Presentation
Premium
Company Announcements
Cutia Therapeutics’ Phase III Trial Results for CU-30101 Accepted for Presentation
10M ago
2487

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >